Clinical Trial Update: INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating INFUSE Bone Graft (rhBMP-2) for transforaminal lumbar interbody fusion in degenerative disease of the lumbosacral spine; the study was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Degenerative Disease

Drugs mentioned

• INFUSE Bone Graft (Recombinant human bone morphogenetic protein-2 (rhBMP-2))

Snippet

Sponsor: Medtronic Spinal and Biologics | Conditions: Lumbar Spine Degeneration | Phase 3 | Status: TERMINATED | Results posted: 2015-10-28